StockDriftsStockDriftsTop 4 Royalty Pharma Sub-Manager, LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| CYTK | CYTOKINETICS, INC | 37.4% | 980.4K | $64.6M | +0.00%(+0) | $59.25(+45.97%) | 2026-03-31 | |
| BCAX | ZENAS BIOPHARMA, INC. | 27.02% | 2.39M | $46.7M | +89.06%(+1.12M) | $17.28(+67.87%) | 2026-03-31 | |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 21.19% | 3.85M | $36.6M | +0.00%(+0) | $7.70(+27.88%) | 2026-03-31 | |
| BHVN | BIOHAVEN LTD | 14.38% | 2.94M | $24.8M | +0.00%(+0) | $13.15(+21.37%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +60.21% | +311.25% |
| Top 20 Holdings Unweighted | +72.81% | +416.04% |
Sign up free to track Royalty Pharma Sub-Manager, LLC, compare funds side by side, and get alerts the moment positions change.